TMDX Q4 2024 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$122M+49.8% YoY

Gross Profit

$72M59.2% margin

Operating Income

$9M7.1% margin

Net Income

$7M5.6% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+11.8%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$6M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$804M

Total Liabilities

$575M

Stockholders' Equity

$229M

Cash & Equivalents

$337M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$122M	$81M	+49.8%
Gross Profit	$72M	$48M	+50.3%
Operating Income	$9M	$3M	+232.1%
Net Income	$7M	$4M	+70.1%

Revenue Segments

Product

$75M100%